JP2002501484A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002501484A5 JP2002501484A5 JP1998538801A JP53880198A JP2002501484A5 JP 2002501484 A5 JP2002501484 A5 JP 2002501484A5 JP 1998538801 A JP1998538801 A JP 1998538801A JP 53880198 A JP53880198 A JP 53880198A JP 2002501484 A5 JP2002501484 A5 JP 2002501484A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3998797P | 1997-03-05 | 1997-03-05 | |
| US60/039,987 | 1997-03-05 | ||
| PCT/US1998/004303 WO1998039363A2 (en) | 1997-03-05 | 1998-03-05 | Immunotoxins and methods of inducing immune tolerance |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002501484A JP2002501484A (ja) | 2002-01-15 |
| JP2002501484A5 true JP2002501484A5 (enExample) | 2005-11-10 |
Family
ID=21908461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP53880198A Ceased JP2002501484A (ja) | 1997-03-05 | 1998-03-05 | 免疫毒素および免疫寛容を誘導する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6632928B1 (enExample) |
| EP (1) | EP1015496B1 (enExample) |
| JP (1) | JP2002501484A (enExample) |
| AT (1) | ATE433998T1 (enExample) |
| AU (1) | AU733898B2 (enExample) |
| CA (1) | CA2284079C (enExample) |
| DE (1) | DE69840913D1 (enExample) |
| WO (1) | WO1998039363A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7288254B2 (en) | 1995-10-30 | 2007-10-30 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services, Nih | Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| WO2001087982A2 (en) * | 2000-05-18 | 2001-11-22 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Immunotoxin fusion proteins and means for expression thereof |
| US7517527B2 (en) | 1995-10-30 | 2009-04-14 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxin with in vivo T cell suppressant activity and methods of use |
| US6632928B1 (en) | 1997-03-05 | 2003-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxins and methods of inducing immune tolerance |
| US7696338B2 (en) | 1995-10-30 | 2010-04-13 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxin fusion proteins and means for expression thereof |
| US7125553B1 (en) | 1996-04-15 | 2006-10-24 | The United States of America as represented by the Department of Health and Human Services c/o Centers for Disease Control and Prevention | Methods of inducing immune tolerance using immunotoxins |
| CA2358435A1 (en) * | 1999-01-08 | 2000-07-13 | Stuart J. Knechtle | Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28 |
| US20020142000A1 (en) * | 1999-01-15 | 2002-10-03 | Digan Mary Ellen | Anti-CD3 immunotoxins and therapeutic uses therefor |
| JP2002541195A (ja) * | 1999-04-14 | 2002-12-03 | アメリカ合衆国 | 移植片に対する免疫寛容を誘導するための、免疫毒素および樹状細胞の成熟を阻害する作用剤を含有する組成物 |
| WO2000078348A1 (en) * | 1999-06-17 | 2000-12-28 | University Of Vermont And State Agricultural College | Autologous adoptive immunotherapy with primed antigen-specific t cells or b cells |
| US6492498B1 (en) | 1999-11-15 | 2002-12-10 | Regents Of The University Of Minnesota | Multimeric immunotoxins |
| AU2002325164B2 (en) * | 2001-07-24 | 2008-12-04 | Debiovision Inc. | Receptor, the use thereof, and mouse antibodies |
| EP2075256A2 (en) | 2002-01-14 | 2009-07-01 | William Herman | Multispecific binding molecules |
| US7105347B2 (en) | 2002-07-30 | 2006-09-12 | Corning Incorporated | Method and device for protein delivery into cells |
| US7691580B2 (en) * | 2003-01-29 | 2010-04-06 | Corning Incorporated | Reverse protein delivery into cells on coded microparticles |
| US20090029460A1 (en) * | 2004-01-26 | 2009-01-29 | Peter Vollmers | Neoplasm-specific polypeptides and their uses |
| WO2008020827A2 (en) * | 2005-08-01 | 2008-02-21 | Biogen Idec Ma Inc. | Altered polypeptides, immunoconjugates thereof, and methods related thereto |
| AU2006306521B2 (en) * | 2005-10-21 | 2011-12-22 | Medical College Of Georgia Research Institute, Inc. | The induction of indoleamine 2,3-dioxygenase in dendritic cells by TLR ligands and uses thereof |
| WO2008088422A2 (en) * | 2006-10-25 | 2008-07-24 | Amgen Inc. | Toxin peptide therapeutic agents |
| EP2162540A2 (en) | 2007-05-22 | 2010-03-17 | Amgen Inc. | Compositions and methods for producing bioactive fusion proteins |
| PT2197903E (pt) * | 2007-09-04 | 2015-01-02 | Us Gov Health & Human Serv | Delecções no domínio ii da exotoxina a de pseudomonas que reduzem toxicidade não específica |
| PE20120630A1 (es) * | 2009-08-17 | 2012-05-26 | Roche Glycart Ag | Inmunoconjugados dirigidos |
| EP2565667A1 (en) | 2011-08-31 | 2013-03-06 | Friedrich-Alexander-Universität Erlangen-Nürnberg | Direction of arrival estimation using watermarked audio signals and microphone arrays |
| WO2025050404A1 (zh) * | 2023-09-08 | 2025-03-13 | 成都维瑾柏鳌生物医药科技有限公司 | 一种药物组合物及其应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4520226A (en) | 1982-07-19 | 1985-05-28 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of graft versus host disease using a mixture of T-lymphocyte specific monoclonal antibody: ricin conjugates |
| ATE101162T1 (de) | 1985-11-13 | 1994-02-15 | Hospital Univ | Durch cys-kodon modifizierte dns. |
| US4981979A (en) | 1987-09-10 | 1991-01-01 | Neorx Corporation | Immunoconjugates joined by thioether bonds having reduced toxicity and improved selectivity |
| WO1989006968A1 (en) | 1988-02-03 | 1989-08-10 | Xoma Corporation | Therapeutic use of anti-t cell immunotoxin for autoimmune diseases |
| IL89504A0 (en) | 1988-03-08 | 1989-09-10 | Univ Wyoming | Diphtheria toxin derivative,process for the preparation thereof and pharmaceutical composition containing the same |
| US5980896A (en) * | 1989-06-30 | 1999-11-09 | Bristol-Myers Squibb Company | Antibodies reactive with human carcinomas |
| CA2076753A1 (en) | 1990-02-26 | 1991-08-27 | Anthony J. Radford | Shuttle plasmid for escherichia coli and mycobacteria |
| US5167956A (en) | 1991-02-11 | 1992-12-01 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxin with in-vivo t cell suppressant activity |
| US5725857A (en) | 1991-02-11 | 1998-03-10 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxin with in vivo T cell suppressant activity and methods of use |
| WO1993015113A1 (en) | 1992-01-24 | 1993-08-05 | Tanox Biosystems, Inc. | An immunotoxin including a cytotoxin with an unpaired cysteine residue in or near its receptor-binding site |
| ATE280235T1 (de) | 1993-03-05 | 2004-11-15 | Wyeth Corp | Plasmid zur herstellung von crm-protein und diphtherie-toxin |
| US5917017A (en) | 1994-06-08 | 1999-06-29 | President And Fellows Of Harvard College | Diphtheria toxin vaccines bearing a mutated R domain |
| US5688781A (en) | 1994-08-19 | 1997-11-18 | Bristol-Myers Squibb Company | Method for treating vascular leak syndrome |
| DE69638145D1 (de) * | 1995-04-14 | 2010-04-22 | Us Gov Health & Human Serv | Verfahren zur herbeiführung einer immuntoleranz mit hilfe von immuntoxinen |
| US6103235A (en) | 1995-10-30 | 2000-08-15 | The United States Of America As Represented By The Department Of Health And Human Services | Methods of inducing immune tolerance using immunotoxins |
| US6632928B1 (en) | 1997-03-05 | 2003-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Immunotoxins and methods of inducing immune tolerance |
| US5747474A (en) * | 1996-07-29 | 1998-05-05 | Immune Modulation, Inc. | Immunosuppression by administration of N6,N6 -disubstituted cAMP's, analogues thereof, and related nucleosides |
| EP0968282A2 (en) | 1997-03-05 | 2000-01-05 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Vectors and methods for expression of mutant proteins |
| US5801193A (en) * | 1997-04-15 | 1998-09-01 | Immune Modulation, Inc. | Compositions and methods for immunosuppressing |
| AU3654499A (en) | 1998-04-22 | 1999-11-08 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| CA2358435A1 (en) | 1999-01-08 | 2000-07-13 | Stuart J. Knechtle | Methods of prolonging transplant survival using immunotoxins and costimulation blockade of cd154 and cd28 |
| US20020142000A1 (en) | 1999-01-15 | 2002-10-03 | Digan Mary Ellen | Anti-CD3 immunotoxins and therapeutic uses therefor |
| JP2002541195A (ja) | 1999-04-14 | 2002-12-03 | アメリカ合衆国 | 移植片に対する免疫寛容を誘導するための、免疫毒素および樹状細胞の成熟を阻害する作用剤を含有する組成物 |
-
1998
- 1998-03-05 US US09/380,484 patent/US6632928B1/en not_active Expired - Lifetime
- 1998-03-05 AU AU65426/98A patent/AU733898B2/en not_active Expired
- 1998-03-05 DE DE69840913T patent/DE69840913D1/de not_active Expired - Lifetime
- 1998-03-05 JP JP53880198A patent/JP2002501484A/ja not_active Ceased
- 1998-03-05 CA CA002284079A patent/CA2284079C/en not_active Expired - Lifetime
- 1998-03-05 AT AT98911483T patent/ATE433998T1/de not_active IP Right Cessation
- 1998-03-05 EP EP98911483A patent/EP1015496B1/en not_active Expired - Lifetime
- 1998-03-05 WO PCT/US1998/004303 patent/WO1998039363A2/en not_active Ceased
-
2003
- 2003-05-09 US US10/435,567 patent/US20030185825A1/en not_active Abandoned